Responses
Immune cell therapies and immune cell engineering
Original research
Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
